Age-Related Macular Degeneration and Diabetic Retinopathy.
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
05 Apr 2022
05 Apr 2022
Historique:
received:
28
03
2022
accepted:
29
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
More than 15 years ago, the results of the pivotal trials supporting the intravitreal use of ranibizumab were published [...].
Identifiants
pubmed: 35455697
pii: jpm12040581
doi: 10.3390/jpm12040581
pmc: PMC9027191
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
J Pers Med. 2021 Sep 04;11(9):
pubmed: 34575662
J Pers Med. 2021 Nov 08;11(11):
pubmed: 34834513
J Pers Med. 2021 Dec 09;11(12):
pubmed: 34945810
J Pers Med. 2021 May 22;11(6):
pubmed: 34067442
N Engl J Med. 2006 Oct 5;355(14):1432-44
pubmed: 17021319
J Pers Med. 2021 Nov 01;11(11):
pubmed: 34834478
BMJ Open. 2019 May 28;9(5):e022031
pubmed: 31142516
J Pers Med. 2021 Aug 23;11(8):
pubmed: 34442470
J Pers Med. 2021 Jun 08;11(6):
pubmed: 34201045
J Pers Med. 2021 May 13;11(5):
pubmed: 34067994
J Pers Med. 2021 Oct 14;11(10):
pubmed: 34683165
J Pers Med. 2021 Nov 16;11(11):
pubmed: 34834560
J Pers Med. 2021 Jul 28;11(8):
pubmed: 34442384
J Pers Med. 2021 Dec 04;11(12):
pubmed: 34945769
J Pers Med. 2021 Nov 25;11(12):
pubmed: 34945728
J Pers Med. 2022 Jan 24;12(2):
pubmed: 35207637
J Pers Med. 2021 Aug 16;11(8):
pubmed: 34442443